170 related articles for article (PubMed ID: 7831358)
21. [Protein C and coagulation in sepsis].
D'Angelo A; Della Valle P; Giudici D; Viganò D'Angelo S
Minerva Anestesiol; 2004 May; 70(5):339-50. PubMed ID: 15181414
[TBL] [Abstract][Full Text] [Related]
22. [Physiologie and cellular regulation of the protein C system].
Vincenot A; Gaussem P
Ann Biol Clin (Paris); 1997; 55(1):17-24. PubMed ID: 9099247
[TBL] [Abstract][Full Text] [Related]
23. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
24. [Protein C, protein S and heparin cofactor II--their significance as the regulatory factors in the blood coagulation cascade].
Shinmyozu K
Rinsho Byori; 1994 Jan; 42(1):9-15. PubMed ID: 8107289
[TBL] [Abstract][Full Text] [Related]
25. [Disseminated intravascular coagulation syndrome and protein C].
Kvasnicka J; Ehler Z; Polívková J; Krska Z; Hájek Z; Malíková I; Horák P
Sb Lek; 2002; 103(2):257-64. PubMed ID: 12688150
[TBL] [Abstract][Full Text] [Related]
26. Recombinant antitrypsin Pittsburgh undergoes proteolytic cleavage during E. coli sepsis and fails to prevent the associated coagulopathy in a primate model.
Harper PL; Taylor FB; DeLa Cadena RA; Courtney M; Colman RW; Carrell RW
Thromb Haemost; 1998 Nov; 80(5):816-21. PubMed ID: 9843177
[TBL] [Abstract][Full Text] [Related]
27. Coagulation inhibitor substitution during sepsis.
Fourrier F; Jourdain M; Tournois A; Caron C; Goudemand J; Chopin C
Intensive Care Med; 1995 Nov; 21 Suppl 2():S264-8. PubMed ID: 8636534
[TBL] [Abstract][Full Text] [Related]
28. Recombinant activated protein C attenuates endothelial injury and inhibits procoagulant microparticles release in baboon heatstroke.
Bouchama A; Kunzelmann C; Dehbi M; Kwaasi A; Eldali A; Zobairi F; Freyssinet JM; de Prost D
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1318-25. PubMed ID: 18451327
[TBL] [Abstract][Full Text] [Related]
29. Baboon model of Escherichia coli sepsis: description of its four stages and the role of tumor necrosis factor, tissue factors, and the protein C system in septic shock.
Taylor FB; Chang AC; Esmon CT; Hinshaw LB
Curr Stud Hematol Blood Transfus; 1991; (58):8-14. PubMed ID: 1954780
[No Abstract] [Full Text] [Related]
30. Endothelial cell activation in cutaneous vasculitis.
Jurd KM; Stephens CJ; Black MM; Hunt BJ
Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
[TBL] [Abstract][Full Text] [Related]
31. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
[TBL] [Abstract][Full Text] [Related]
33. Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications.
Aderka D
Isr J Med Sci; 1991 Jan; 27(1):52-60. PubMed ID: 1995504
[TBL] [Abstract][Full Text] [Related]
34. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
35. Inflammation, endothelium, and coagulation in sepsis.
Schouten M; Wiersinga WJ; Levi M; van der Poll T
J Leukoc Biol; 2008 Mar; 83(3):536-45. PubMed ID: 18032692
[TBL] [Abstract][Full Text] [Related]
36. Protein S as cofactor for TFPI.
Hackeng TM; Rosing J
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2015-20. PubMed ID: 19661488
[TBL] [Abstract][Full Text] [Related]
37. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort.
Sakkinen PA; Cushman M; Psaty BM; Kuller LH; Bajaj SP; Sabharwal AK; Boineau R; Macy E; Tracy RP
Thromb Haemost; 1998 Jul; 80(1):134-9. PubMed ID: 9684799
[TBL] [Abstract][Full Text] [Related]
38. [Endothelial cells and coagulation abnormalities].
Uchiba M; Okajima K
Rinsho Byori; 2000 Apr; 48(4):308-13. PubMed ID: 10810875
[TBL] [Abstract][Full Text] [Related]
39. Infusion of phospholipid vesicles amplifies the local thrombotic response to TNF and anti-protein C into a consumptive response.
Taylor FB; He SE; Chang AC; Box J; Ferrell G; Lee D; Lockhart M; Peer G; Esmon CT
Thromb Haemost; 1996 Apr; 75(4):578-84. PubMed ID: 8743182
[TBL] [Abstract][Full Text] [Related]
40. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
